TrialInternational journal of clinical oncology2020

Hand-foot syndrome and survival in patients with advanced non-small-cell lung cancer receiving anlotinib: a subgroup analysis of data from the ALTER 0303 study.

Xueli Nan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.